Service needs of people living with HIV in the UK (Positive Voices 2022): a cross-sectional survey [0.03%]
英国HIV感染者的需求（Positive Voices 2022）：横断面调查结果
Anne Williamson,Fiona C Lampe,Adamma Aghaizu et al.
Anne Williamson et al.
Background: Despite accessible and effective HIV treatment, the health and wellbeing of people with HIV can be negatively affected by social and economic disadvantage and stigma. We assessed needs and unmet needs for heal...
Histoplasmosis: a missing piece in the global efforts to end HIV deaths [0.03%]
荚膜组织胞浆菌病：终结艾滋病死亡全球努力中缺失的一环
Alessandro C Pasqualotto,Thuy Le,Tarsila Vieceli et al.
Alessandro C Pasqualotto et al.
Histoplasmosis is a leading opportunistic infection and cause of mortality in people with advanced HIV disease. Yet, histoplasmosis is largely neglected in the global HIV response. Previously considered endemic only in the region of the Ame...
Tony Kirby
Tony Kirby
The Lancet Hiv
The Lancet Hiv
The impact of HIV stigma and discrimination on HIV testing, antiretroviral treatment, and viral suppression in Africa: a pooled analysis of population-based surveys [0.03%]
非洲人口基于调查的汇总分析：艾滋病毒耻辱和歧视对艾滋病毒检测、抗逆转录病毒治疗和病毒抑制的影响
Carla M Doyle,Salome Kuchukhidze,James Stannah et al.
Carla M Doyle et al.
Background: UNAIDS' ending AIDS targets include ensuring that less than 10% of people with HIV, at risk of HIV, or affected by HIV experience HIV stigma and discrimination. We aimed to estimate the effect of HIV stigma an...
Sarah K Calabrese
Sarah K Calabrese
Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial [0.03%]
每日一次固定剂量组合多拉韦林（100毫克）与伊斯拉特韦（0.25毫克）对比比克塔韦、恩曲他滨和替诺福韦阿拉芬胺用于初始HIV-1治疗：3期随机对照双盲非劣效性试验的48周结果
Jürgen K Rockstroh,Sheetal Kassim,Roger Paredes et al.
Jürgen K Rockstroh et al.
Background: Doravirine and islatravir is a two-drug regimen being investigated for the treatment of HIV-1. This study evaluated efficacy and safety of once daily doravirine and islatravir versus bictegravir, emtricitabine...
Post-mortem characterisation of HIV-associated under-5 deaths in the CHAMPS network: population-based mortality surveillance [0.03%]
基于人口的死亡率监测指导下与HIV相关的5岁以下儿童死因特征研究：CHAMPS网络项目结果报告
Inacio Mandomando,Zachary J Madewell,Portia C Mutevedzi et al.
Inacio Mandomando et al.
Background: Despite widespread implementation of vertical transmission prevention and paediatric HIV programmes, HIV remains a leading cause of child mortality. We analysed HIV-attributed deaths in the Child Health and Mo...
Irene Njuguna,Grace John-Stewart
Irene Njuguna